GDUFA III

GDUFA III: Controlled Correspondence

GDUFA III: Facility Readiness

DMF Workshop: GDUFA III Enhancements and Structured Data Submissions – Session 3

GDUFA III MCRM External Training Presentation final

A Deep Dive: GDUFA III Scientific Meetings

ANDA Submissions – Amendments to Abbreviated New Drug Applications under GDUFA

DMF Workshop: GDUFA III Enhancements and Structured Data Submissions – Keynote and Session 1

Part-2 GDUFA lll updates l Generic Drug User Fee Act l FDA l Regulatory Affairs l #pharmaceuticals

DMF Workshop: GDUFA III Enhancements and Structured Data Submissions – Session 4 and Closing Remarks

GDUFA III Goal Date Illustrations

Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval

GDUFA II Training - Performance Goals, Vince Sansone

Part-1 GDUFA l Generic Drug User Fee Act l FDA l Regulatory Affairs l #pharmaceutical#regulations

ANDAs: Pre-Submission Facility Correspondence (PFC) Related to Prioritized Generic Drug Submissions

GDUFA I Accomplishments

GDUFA II Training - Pre ANDA Product Development Meetings, Robert Lionberger

GDUFA II Training IR and DR Letters, Michael Folkendt

fgygrrfyyhgffhhh huh uh HD set yh or f GB ji it yi kg DUI or et uh ji if fyi yi j yr t5 TCU i ji

DMF Workshop: GDUFA III Enhancements and Structured Data Submissions – Session 2

Features of GDUFA II

GDUFA II – Review Timelines (14of27) Generic Drugs Forum 2018

GDUFA lll updates l Generic Drug User Fee Act l FDA l #pharma #regulatoryaffairs

Crushing Crunchy & Soft Things by Car! EXPERIMENT: Car vs Coca Cola, Fanta, Mirinda Balloons

Preparing for GDUFA II User Fees (6/28) Generic Drugs Forum 2017